Clinical trials
Active, not recruiting Phase 1 Rectal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 2 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 2 |
| Amal Therapeutics | 1 |
| Eli Lilly and Company | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair | 1 |
| National Cancer Institute (NCI) | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
| Revolution Medicines, Inc. | 1 |
| University of Texas Southwestern Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rectal Neoplasms | 11 |
| Colonic Neoplasms | 8 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Colorectal Neoplasms | 5 |
| Esophageal Neoplasms | 4 |
| Lung Neoplasms | 4 |
| Ovarian Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Carcinoma, Pancreatic Ductal | 2 |
| Carcinoma, Renal Cell | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.